CA
ABBV icon

CoreCap Advisors’s AbbVie ABBV Stock Holding History

CoreCap Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.28M Sell
20,967
-21,425
-51% -$4.61M 0.16% 151
2026
Q1 		$9.22M Buy
42,392
+24,843
+142% +$5.51M 0.31% 63
2025
Q4 		$4.01M Sell
17,549
-296
-2% -$67.4K 0.14% 149
2025
Q3 		$4.13M Buy
17,845
+798
+5% +$163K 0.15% 137
2025
Q2 		$3.16M Sell
17,047
-36
-0.2% -$6.69K 0.13% 153
2025
Q1 		$3.58M Buy
17,083
+725
+4% +$141K 0.16% 126
2024
Q4 		$2.91M Buy
16,358
+2,254
+16% +$414K 0.13% 149
2024
Q3 		$2.79M Buy
14,104
+752
+6% +$140K 0.13% 162
2024
Q2 		$2.29M Buy
13,352
+134
+1% +$22.2K 0.24% 86
2024
Q1 		$2.41M Buy
13,218
+651
+5% +$112K 0.13% 162
2023
Q4 		$1.95M Buy
12,567
+249
+2% +$36.3K 0.13% 168
2023
Q3 		$1.84M Sell
12,318
-11,786
-49% -$1.73M 0.13% 152
2023
Q2 		$3.25M Buy
+24,104
New +$3.53M 0.23% 86
2022
Q4 		$3.81M Buy
23,591
+2,178
+10% +$334K 0.27% 67
2022
Q3 		$2.87M Buy
21,413
+198
+0.9% +$28.4K 0.24% 75
2022
Q2 		$3.25M Sell
21,215
-855
-4% -$131K 0.25% 69
2022
Q1 		$3.58M Buy
22,070
+1,005
+5% +$146K 0.25% 72
2021
Q4 		$2.85M Buy
+21,065
New +$2.49M 0.19% 96

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CoreCap Advisors's ABBV Position: Q2 2026 in Review

CoreCap Advisors reduced its AbbVie (ABBV) stake by 51% in Q2 2026, selling an estimated $4.61M and leaving 20,967 shares worth $5.28M. The position accounts for 0.16% of the portfolio, ranked #151.

CoreCap Advisors first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $9.22M in Q1 2026. 1,213 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • CoreCap Advisors held 20,967 shares of AbbVie worth $5.28M as of Q2 2026.
  • CoreCap Advisors sold 21,425 AbbVie shares in Q2 2026, an estimated $4.61M.
  • AbbVie made up 0.16% of CoreCap Advisors's portfolio in Q2 2026, its #151 holding.
  • CoreCap Advisors first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • CoreCap Advisors's AbbVie position peaked at $9.22M in Q1 2026.
  • 1,213 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.